ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INHC Induction Healthcare Group Plc

12.50
0.00 (0.00%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Induction Healthcare Group Plc LSE:INHC London Ordinary Share GB00BJ0M3545 ORD 0.5P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.00% 12.50 8,507 01:00:00
Bid Price Offer Price High Price Low Price Open Price
11.00 14.00 12.50 12.50 12.50
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 12.88M -17.38M -0.1882 -0.66 11.55M
Last Trade Time Trade Type Trade Size Trade Price Currency
10:21:07 O 904 11.55 GBX

Induction Healthcare (INHC) Latest News

Induction Healthcare (INHC) Discussions and Chat

Induction Healthcare Forums and Chat

Date Time Title Posts
20/5/202409:09Induction Healthcare63

Add a New Thread

Induction Healthcare (INHC) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type

Induction Healthcare (INHC) Top Chat Posts

Top Posts
Posted at 25/5/2024 09:20 by Induction Healthcare Daily Update
Induction Healthcare Group Plc is listed in the Business Services, Nec sector of the London Stock Exchange with ticker INHC. The last closing price for Induction Healthcare was 12.50p.
Induction Healthcare currently has 92,380,300 shares in issue. The market capitalisation of Induction Healthcare is £11,547,538.
Induction Healthcare has a price to earnings ratio (PE ratio) of -0.66.
This morning INHC shares opened at 12.50p
Posted at 01/5/2024 11:59 by citys2874
NHS ENGLAND Contract news should catapult this share due very soon
Posted at 29/4/2024 09:46 by citys2874
Induction Healthcare Group PLC



Full Year Trading Update



London, UK - 29 April 2024: Induction Healthcare Group PLC ("Induction", the "Company", or the "Group"; AIM: INHC), a leading digital health platform driving transformation of healthcare systems, today announces the following trading update for the year ending 31 March 2024.



Financial Highlights (unaudited)

· Revenues of approximately £14.1m (FY23: £13.6m), broken down as follows:

o Attend Anywhere: £8.5m

o Zesty: £4.9m

o Guidance: £0.7m

· Adjusted EBITDA* expected to be in line with market expectation at approximately £0.3m (FY23: -£3.6m)

· Gross margin improvement to 77.9% (FY23: 63.1%)

· Net cash £3.7m (31 March 2023: £4.3m)



* Adjusted EBITDA is Operating result from continuing operations before depreciation (£0.1m), amortisation (£4.3m) and net of non-cash/ non-operating items (£0.2m)



Operational Highlights

· New NHS patient portal contracts compensate for downward pressure on video pricing.

· Completed effective cost containment and margin enhancement programme.

· Achieved objective of self-sustaining growth and cash flow breakeven.

· Signed a total of £3.4m (includes previously-announced contracts) in contracts with NHS England Trusts to:

o Further integrate Zesty with Oracle Cerner and widely-used diagnostic booking systems (Cris and Soliton);

o Enhance Form Builder module to support waitlist validation; and

o Build new functionality, such as digitising maternity records.

All platform and product enhancements underpin valuable upsell opportunities for FY25.

· Launched Zesty in 4 new Trusts, including a new contract award in Q4 with George Elliot Hospital NHS Trust. Three additional Trusts are contracted to launch Zesty within the next 12 months.

· Successfully built and launched the first phase of our integrated product which enables a patient to view and launch their Attend Anywhere consultation from within Zesty. Five customers have already purchased the integrated functionality.

· NHS Wales agreed to a 9-month extension for £730,858 in order to prepare for a new procurement, which was expected under NHS procurement rules given the length of a new contract.



Induction expects to release its audited results for the year ending 31 March 2024 on 1 July 2024.
Posted at 23/4/2024 12:45 by citys2874
NHS England Renewal and hospitals tend to buy in April make this very cheap and should double up in price between now and end of May
Posted at 17/4/2024 16:52 by citys2874
Remote consultation services in secondary care. Should see Induction Attend Anywhere ("AA") contracts have been successfully extended or renewed across NHS England ...expect 2-3 year contracts RNS very soon....this RNS should see share price bounce up past 20.00s
Posted at 17/4/2024 13:59 by citys2874
very cheap at this price ....could see this bounce back to mid 20.00s very soon...multi-bagger at this price
Posted at 09/1/2023 11:08 by hybrasil
Just don't understand the maths here.
This was floated at 115p a share in 2019. The mcap at flotation was 35m. The shares have since fallen to 22p but the mcap is still 20m.. How come?
Posted at 21/5/2021 10:02 by dekle
The drop yesterday made the placing price seem less of a discount
Posted at 25/3/2021 11:13 by 74tom
Strongly suspect that a placing is on the way here;

Cash at 30th September = £5.01m
Operating cash burn in 6 months to 30th September = £2.4m
Probable cash balance at 25/03 = £2.5m or so

Enough to last another 6 months.

5 x RNS releases in the last 14 trading days is always a sure sign they are trying to increase the share price and thus reduce dilution. Admirable, but whether it's good for PI's depends on the discount.

Interesting to see what happens & whether they provide any clarity on revenues, as recent RNS's are missing any financial figures / are pure fluff.
Posted at 15/3/2021 22:56 by megasonic
Built up a healthy holding in INHC these past few weeks. RNSs on a number of contract wins in the last few days and the resulting share price action suggest this was a wise investment.INHC looks a real solid MedTech business, seems to have plenty of buy in from medical professionals.Expecting a Trading Update next month that will hopefully reveal decent revenue growth and potential for future contract wins. Currently only 20% of float available to PIs so share price will see big moves on low volumes. share price might see a big bounce if TU is positive, but IMO the real reward will come from a long term hold.
Posted at 09/7/2020 12:51 by sphere25
Scubadiverr,

In this instance, it's the well publicised Woodford debacle and Link Fund Solutions (holding 10.34% of the company's stock as per the RNS dated 09/06/2020) acting as administrator to place the funds. It has been a similar theme recently at the likes of PURP, TRX and DDDD.

Identifying an overhang in general would be an interesting question. Beyond news highlighting distressed or forced fund sellers, you can look for persistent sellers via holding RNS and where stocks appear to be artificially suppressed from reaching a higher valuation.

An example of this would be TSL where Simon Thompson has recently written an article on Investors Chronicle highlighting the increasing disparity between the valuation of the stock relative to the ever increasing value of the stake it has in AfterPay.

TSL has substantially lagged the move higher in the company it owns a stake in and the holding RNS show that this appears to be because of Lombard using the opportunity of higher market demand to sell down a very significant stake. They have sold down their stake from 18.7% of the company in mid May to 4.51% as at the 30th June.

There have been numerous overhang plays in the past, but note that there is no guarantee that the stock will rally strong too - it does depend on the fundamentals of the stock too, short term rises can be sold into or stale moves can occur. INHC is such an example as it's highly speculative and could find other sellers in the market wanting to sell at the overhang clearance levels, so it ultimately depends on the fundamentals.

Clearly if this stock starts show more on the fundamental front, it changes the picture entirely.

Hope this helps

All imo

DYOR
Induction Healthcare share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock